Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02847000
Title p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Yogen Saunthararajah
Indications

pancreatic adenocarcinoma

pancreatic carcinoma

Therapies

Decitabine + Tetrahydrouridine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.